Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Mar 5, 2020
Finance
Amunix’s Omega-led $73M A round to support shift to drug development
...did new investors Longitude Capital, Redmile Group, Polaris Partners, Casdin Capital, Two River, Venrock and
Delian Capital
...
Read More
BioCentury
|
Dec 11, 2019
Financial News
Dec. 10 Financial Quick Takes: Inscripta, Aurinia, Akeso, Ribo, Hummingbird, ImmunOs, Peregrine
...to $60 million. Existing investors Heritas Capital and Seeds Capital, as well as new investors
Delian Capital
...
Read More
BioCentury
|
Aug 28, 2019
Financial News
HiFiBiO’s $67M series C attracts Kite, international syndicate
...China, VI Ventures, Legend Star Capital and LYFE Capital also participated, as did new investors
Delian Capital
...
Read More
BioCentury
|
Dec 8, 2017
Financial News
Anti-infectives company MicuRx raises RMB100M
...RMB100 million ($15.1 million) on Dec. 6 in a private placement led by existing investors
Delian Capital
...
Read More
BioCentury
|
Dec 6, 2017
Financial News
Anti-infectives company MicuRx raises RMB100M
...Hayward, Calif.) raised RMB100 million ($15.1 million) in a private placement led by existing investors
Delian Capital
...
Read More
BioCentury
|
Oct 3, 2016
Financial News
MicuRx completes venture financing
...Venture financing Raised: $55 million Investors: GP Healthcare Capital; GP TMT Capital; 3E Bioventures Capital;
Delian Capital
WIR...
Read More
BioCentury
|
Sep 26, 2016
Financial News
MicuRx raises $55M in series C
...round led by GP Healthcare Capital. New investors GP TMT Capital, 3E Bioventures Capital and
Delian Capital
...
Read More
Items per page:
10
1 - 7 of 7
BioCentury
|
Mar 5, 2020
Finance
Amunix’s Omega-led $73M A round to support shift to drug development
...did new investors Longitude Capital, Redmile Group, Polaris Partners, Casdin Capital, Two River, Venrock and
Delian Capital
...
Read More
BioCentury
|
Dec 11, 2019
Financial News
Dec. 10 Financial Quick Takes: Inscripta, Aurinia, Akeso, Ribo, Hummingbird, ImmunOs, Peregrine
...to $60 million. Existing investors Heritas Capital and Seeds Capital, as well as new investors
Delian Capital
...
Read More
BioCentury
|
Aug 28, 2019
Financial News
HiFiBiO’s $67M series C attracts Kite, international syndicate
...China, VI Ventures, Legend Star Capital and LYFE Capital also participated, as did new investors
Delian Capital
...
Read More
BioCentury
|
Dec 8, 2017
Financial News
Anti-infectives company MicuRx raises RMB100M
...RMB100 million ($15.1 million) on Dec. 6 in a private placement led by existing investors
Delian Capital
...
Read More
BioCentury
|
Dec 6, 2017
Financial News
Anti-infectives company MicuRx raises RMB100M
...Hayward, Calif.) raised RMB100 million ($15.1 million) in a private placement led by existing investors
Delian Capital
...
Read More
BioCentury
|
Oct 3, 2016
Financial News
MicuRx completes venture financing
...Venture financing Raised: $55 million Investors: GP Healthcare Capital; GP TMT Capital; 3E Bioventures Capital;
Delian Capital
WIR...
Read More
BioCentury
|
Sep 26, 2016
Financial News
MicuRx raises $55M in series C
...round led by GP Healthcare Capital. New investors GP TMT Capital, 3E Bioventures Capital and
Delian Capital
...
Read More
Items per page:
10
1 - 7 of 7
Previous page
Next page